Nipah Virus Outbreak Investigation in Kerala, India

Similar documents
Animal reservoirs for Nipah virus

Statistical Analysis of Nipah Virus Using R

Strengthening Epidemiology Capacity Using a One Health Framework in South Asia

EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Unit G5 - Veterinary Programmes

Regional Workshop on AMR in South East Asia Penang (Malaysia): March 2018

The Ebola Crisis & Innovative WASH Solutions. September 28, 2016

National Action Plan development support tools

Situation update of dengue in the SEA Region, 2010

Rabies in Georgia National Center for Disease Control & Public Health (NCDC) Georgia Paata Imnadze, M.D. Ph.D

of Emerging Infectious Diseases in Wildlife Trade in Lao

Activities for Zoonotic Diseases in Cambodia

NATIONAL VECTOR BORNE DISEASE CONTROL PROGRAMME (NVBDCP)

Competent Authority response to the report recommendations received on 24 August 2016

The Permanent Secretary, Ministry of Public Health and Sanitation. The Permanent Secretary, Ministry of Livestock Development

Albania Inception workshop of the project

NAP on AMR: Singapore

Prevalence of Aedes aegypti - The vector of Dengue/ Chikungunya fevers in Bangalore City, Urban and Kolar districts of Karnataka state

The WHO Strategy for managing zoonotic public health risks at the human-animal interface

What do we need to do if rabies is reintroduced into an area after a period of absence?

World Organisation for Animal Health

UW College of Agriculture and Natural Resources Global Perspectives Grant Program Project Report

Good governance and the evaluation of Veterinary Services

Surveillance of animal brucellosis

Key elements to organise a mass dog vaccination campaign

Assessment Panel mapping document for

Introduction to Biorisk and the OIE Standard

EU strategy to fight against Antimicrobial Resistance

CHALLENGES AND COLLABORATION

ONE HEALTH AND THE POWER OF PLATFORMS. One Health Models for Cross-Sectoral Coordination on Zoonotic Diseases

OIE Role in International Trade

Dr Sumathy Puvanendiran, BVSc,M.Phil,PhD(USA) Veterinary Research Officer Dept of Animal Production & Health Sri Lanka

11-ID-10. Committee: Infectious Disease. Title: Creation of a National Campylobacteriosis Case Definition

ANNEX. to the. Commission Implementing Decision

A World United Against Infectious Diseases: Cross Sectoral Solutions

Second Meeting of the Regional Steering Committee of the GF-TADs for Europe. OIE Headquarters, Paris, 18 December 2007.

Strengthening capacity for the implementation of One Health in Viet Nam, Phase 2 (SCOH2) TERMS OF REFERENCE

General Q&A New EU Regulation on transmissible animal diseases ("Animal Health Law") March 2016 Table of Contents

OIE Reference Laboratory Reports Activities

The veterinary control system of Thailand:

(Non-legislative acts) DECISIONS

ZOONOSIS SURVEILLANCE SYSTEMS IN COTE D IVOIRE IN THE CONCEPT OF ONE HEALTH : STRENGTHS, CHALLENGES AND PERPECTIVES

OIE global strategy for rabies control, including regional vaccine banks

Country Report on National Stray Dogs situation Report from Republic of Serbia

Wageningen Bioveterinary Research. Biomedical and veterinary research to safeguard animal and public health

Campylobacter infections in EU/EEA and related AMR

OIE Regional Commission for Europe Regional Work Plan Framework Version adopted during the 85 th OIE General Session (Paris, May 2017)

OIE capacity-building activities

NATIONAL PLAN FOR FISH HEALTH MANAGEMENT Submitted by:

The Philippine Action Plan to Combat Antimicrobial Resistance: One Health Approach

Technical assistance for the Animal Health Department of the KVFA and the Food and Veterinary Laboratory (Kosovo) - Deliverable 1.

MAIL ORDER HATCHERIES: OPERATIONAL AND DISTRIBUTION LOGISTICS, SALMONELLA INTERVENTION ACTIVITIES AIMED AT PREVENTION OF HUMAN SALMONELLOSIS

Resolution adopted by the General Assembly on 5 October [without reference to a Main Committee (A/71/L.2)]

Veterinary Public Health (VPH)

Antimicrobial Resistance at human-animal interface in the Asia-Pacific Region

Report by the Director-General

Pan-Canadian Framework and Approach to Antimicrobial Resistance. Presentation to the TATFAR Policy Dialogue September 27, 2017

Aide mémoire for environmental conditions and treatment of biological models

Preventing Clostridium difficile Infection (CDI)

The Veterinary Epidemiology and Risk Analysis Unit (VERAU)

One Health tripartite initiatives Updates from WHO perspective to address zoonoses and AMR issues

Use of oral Cotrimoxazole and injectable Gentamicin in module 6 & 7 of ASHA program

SURVEILLANCE IN ACTION: Introduction, Techniques and Strategies

THE GOVERNMENT OF FIJI FIJI NATIONAL ANTIMICROBIAL RESISTANCE ACTION PLAN

National Pig Health Council. Code of Practice for Importation of Fresh Boar Semen into Ireland

Reducing Time to Initial Antibiotic Dose in Pneumonia Patients

Surveillance of AMR in PHE: a multidisciplinary,

Combating Antimicrobial Resistance: A Manufacturing Perspective

OIE Collaborating Centres Reports Activities

Incentives and disincentives for disease surveillance and reporting The BSE case study

A CAREER IN VETERINARY MEDICINE

OIE Standards on biosecurity and compartmentalisation

ANIMAL RABIES IN NEPAL AND RACCOON RABIES IN ALBANY COUNTY, NEW YORK

Terrestrial and Aquatic Manuals and the mechanism of standard adoption

Experience of Malaysia With OIE Standards. Jamaluddin A.A. Department of Veterinary Services Ministry of Agriculture and Agro based Industry Malaysia

JMSCR Vol 04 Issue 09 Page September 2016

SECOND REPORT FROM THE COMMISSION TO THE COUNCIL

The Authority for Biological and Biomedical Models (ABBM) The Hebrew University

Antimicrobial Stewardship: The South African Perspective

Highlights on Hong Kong Strategy and Action Plan on Antimicrobial Resistance ( ) (Action Plan)

Evaluation of EU strategy to combat AMR

University Council on Animal Care

REPORT ON THE ANTIMICROBIAL RESISTANCE (AMR) SUMMIT

21st Conference of the OIE Regional Commission for Europe. Avila (Spain), 28 September 1 October 2004

Antimicrobial Stewardship Northern Ireland

ENVIRONMENT, HEALTH AND SAFETY POLICY

General presentation of the OIE

Standard requirements for the submission of programmes of eradication and monitoring of TSE

Health Risks from Pet Wild Animals

GOOD GOVERNANCE OF VETERINARY SERVICES AND THE OIE PVS PATHWAY

OIE laboratory network on diseases of camelids Final report

ANNEX. to the COMMISSION IMPLEMENTING DECISION

Rabies Prevention and Control Protocol, 2018

Mandate of OIE Reference Centres Capacity Building Support and Networking

Nipah Virus outbreak in the World

lasting compassion and

An evaluation study of mass drug administration of DEC tablet in a North-Eastern district of Andhra Pradesh

Support for OIE Member Countries OIE PVS / Gap Analysis, Reference Laboratories and twinning programmes

One Health and Enteric Disease

Standard Operating Procedure for Rabies. November Key facts

Managing AMR at the Human-Animal Interface. OIE Contributions to the AMR Global Action Plan

Transcription:

Nipah Virus Outbreak Investigation in Kerala, India 1

Introduction Nipah virus infection was first identified in Sept, 1998 in Ipoh, Malaysia In Malaysia & Singapore, most cases were in individuals handling pigs Outbreaks in Bangladesh reported in 2001, 2003, 2004 and 2007-15 (every year ) In India: Siliguri, West Bengal (in Jan-Feb 2001); Nadia, West Bengal (in Jan-Apr 2007) Outbreaks in India & Bangladesh were not associated with disease in pigs 2

Situation for Nipah Virus Infection-India Month /Year Location No. of Cases No. of Deaths Case Fatality Rate Source Feb 2001 Siliguri 66 45 68% WHO April 2007 Nadia 5 5 100% WHO May* 2018 Kerala 19 17 89.5% NCDC, MoHFW *As on 29.07.2018 (Last case reported on 31 st May, 2018) Index case/death not lab confirmed 3

Nipah virus infection in Kerala: Initial report On May 19-20, outbreak of NiV reported in Kozhikode district of Kerala State/district administration activated Case suspected in Baby Hospital, diagnosed as NiV by Manipal lab and confirmed by NIV, Pune State action initiated: suspect linked to Index case Epidemiological and lab investigation initiated active case search in the area 4

Action Taken -MoHFW Hon ble HFM deputed two central teams to the affected area 1 st team reached on 21 st May, 2018 started epidemiological investigation. reviewed the situation in affected areas and public health measures with the Health Minister of Kerala, Addl. CS, DHS & SSO 2 nd team reached on 22 nd May, 2018 reviewed triage, isolation, sample collection and clinical management in the district hospital. hospital visit and review with hospital staff Regular reviews by Hon ble HFM and Hon ble MoS- in addition to Sec.(H), AS(H), JS(PH) and DGHS

Action Taken -MoHFW Epidemiological investigation initiated Line list creation and Contact tracing (n=2600) Case definitions, Guidelines on contact tracing issued Advisories issued for Health care workers and General public Strategic Health Operation Centre activated at NCDC for monitoring Nipah virus outbreak, coordination with field teams/ other states Alert for AES cases: possible history of travel / contact Rumour recording & management Activities review by Director, field teams and experts on daily basis

Epidemiological investigation Document/previous report review Literature review - WHO/CDC Report and guidelines of Bangladesh Report of Siliguri & Nadia outbreaks Discussion with members of earlier teams Field visit to PHC Chengaroth (Perambra Block) house of index case (Sabith) affected area and block hospitals in both the districts 7

Field observations Index case: Muhammad Sabith, 26 year old male from Kozhikode Date of onset: 3 May, 2018 Date of death: 5 May 2018 Died in Govt. Medical College Kozhikode, was earlier admitted to Perambara Taluka Hospital and Baby Memorial Hospital Possible date of infection:? 11-27 April, 2018- based on documented incubation period of disease (4 to 21 days) 8

Distribution of Cases and Death- Nipah Outbreak Kerala Total cases (including index case) 19 Total deaths (including index case) 17 Total lab confirmed cases 18 ( 10 males, 8 females) Total deaths amongst lab confirmed cases 16 (9 males, 7 females) No cases & deaths reported since 1 st June 2018 Tested Total number of samples Positives Negative 337 18 (5.6%) 319(94.4%) 9

Descriptive Analysis of Nipah cases (n=19) Total cases Male (%) 11 (58) Female (%) 8 (42) 19 (18 Laboratory confirmed) Deaths (Case fatality rate) 17 (89.5% ) (16 Laboratory confirmed: 89%) Median age (range) Median Incubation period (range) Median duration between onset and admission (n=19) (range) 32 years (19-75 years) 11 days (8-14 days) 3 days (1-8 days) Median duration between admission and death (n=17) (range) Median duration between onset and death (n=17) (range) 2 days (1-12 days) 7 days (2-14 days) 10

Distribution of Nipah cases by date of death (n=19) 5 4 Community contacts Hospital Contacts Family contacts Index case 3 Deaths 2 1 0 1 3 5 7 9 11 13 15 17 19 21 23 25 27 29 31 May 2018 Date of Death 11

Distribution of Nipah cases by residence 12

Contact Tracing of Cases (n=19) Asokan Sijitha Salih Sindhu Mariyam Kalyani Index Case Family Contacts Hospital Contacts Community Contacts Moosa Velayudan Sabith Janaki Lini Akhil Ismail Ubeesh Rajan Rasin Ajanya Abin Madhusoodan 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 May 2018 Date of Illness Onset 13

Field observations?possible transmission route to index case Fruit Bats (flying fox)/other animals (rabbits, pigs, pigeons), contaminated Fruits/articles?? Human to human: Siliguri / Bangladesh workers/travel of index case Transmission dynamics of outbreak Family Health facility Community contacts Gaps in enlisting contacts, period of infectivity, active case search, contact tracing, home quarantine, PPEs use (HCWs), duration of contact tracing, risk communication (to general public and HCW), Disinfection SOPs

Team 2: Health facility observations All areas identified for Nipah treatment visited by the Central Team. Protocol followed for treatment including ventilator management assessed through the case sheets of the victims who died/ those undergoing treatment. The hospital infection control practices were reviewed. The hospital logistics to support Nipah outbreak reviewed The information management system at the hospital/ district IDSP reviewed.

Observations The risk reduction measures instituted by the GMC, Kozhikode need substantial strengthening. Risk communication to internal stakeholders lagging. The infrastructure support inappropriate: fever triage and treatment of Nipah suspect and confirmed cases (patients kept at 4 different locations in MC, Kozhikode and in 2 private hospitals). The treatment protocol especially the ventilator management protocol was found to be inapt. Sample testing reports did not mention date of sample collection: delay in reports from Manipal Institute of Virological Research, Manipal (on an average the samples were reported with 3-4 days delay) (whereas it takes only 6 hours for performing an RT/ PCR). The hospital infection control practices were found lagging and had major gaps. The knowledge and skills for HICP was found deficient. The hospital was found short of required logistics for undertaking standard precautions.

Actions taken by the Central Team The physical facility for managing suspect & confirmed Nipah cases identified and layout planning discussed with engineering Department. The ground floor of the Pay Ward was found appropriate and recommended appropriate modification to provide optimal standard, contact, droplet and airborne precautions for a Nipah Treatment. Detailed clinical case management protocol prepared and handed over to Principal, GMC, Kozhikode. Arrangements were made to train 5 specialists on ventilator management protocol at Safdarjung Hospital, New Delhi from 28 th May - 2 nd June, 2018. NIV Branch at Alleppy was activated with full complement of trained staff drawn from NIV, Pune. Two skill based training workshops each of 4 hours duration were held at GMC, Kozhikode on infection prevention control practices. About 300 participants drawn from the relevant departments attended.

Actions taken by the Central Team Dedicated staff trained for sample collection and transportation in the procedure for sample collection. Interacted with the PSM Department for their meaningful participation in event based surveillance and data management. Two meetings were held with HODs of the hospital departments to clear their queries on clinical management/ infection prevention. The micro-plan for event based surveillance prepared. ASHAs/ Anganwadi Workers of the epicenter sensitized on the disease, infection control practices and their role in implementation of the micro-plan Meetings with community leaders and IMA doctors to clear their queries Provision of logistic support

Actions taken by the Central Team Guidelines/reference materials during NiV outbreak: to the state Information about Nipah Virus Case definition of Nipah Virus Disease Hospital Infection Control for Nipah Virus Guidelines for Sample collection and Transportation for Nipah Virus Clinical management guidelines for suspected and Confirmed case of Nipah Virus Guidelines for safe disposal confirmed Nipah Patients of dead bodies of Information for General Public and Advisory for Health care personnel

Animal Sample results Species Number tested Test Result Bat 55 Porcine 8 Bovine 5 Conventional nested RT-PCR and real time RT-PCR 10 Bat Samples positive for Nipah viral genome by NIV Pune Caprine 5 Samples collected from in and around Changaroth village, Kozhikode, Kerala 20

Other Activities Nipah alert issued to other states VCs carried out with all States through IDSP Network- clarify doubts on Nipah virus diseases States advised to remain vigilant and to be prepared for any suspected event of Nipah virus diseases Daily Media scanning (print/electronic and social media) Advisories uploaded on NCDC website and shared with all the States Brief on Nipah Virus disease including case definition (suspect & confirm), contact tracing, treatment and clinical management protocol Advisory for General Public Advisory for Health Care Personnel Guidelines and SoPs for sample collection for Nipah Virus Hospital infection control guidelines Laboratory Biosafety guidelines Guidelines for disposal of human remains. 21

Suspected AES cases tested for Nipah virus infection in NIV Pune (n=15) State District No of suspect cases Result Telangana Hyderabad 2 Negative, RT-PCR Maharashtra Sholapur 1 Negative, RT-PCR & Negative for Nipah Ig M ELISA Mumbai 1 Negative, RT-PCR & Negative for Nipah Ig M ELISA Pune 1 Negative, RT-PCR & Negative for Nipah Ig M ELISA Goa Panaji 1 Negative, RT- PCR Karnataka Tumkur 1 Negative, RT- PCR Himachal Solan 6 Negative, RT- PCR Pradesh West Bengal Kolkata 2 Negative for Nipah 22

Actions under IHR NFP-IHR immediately notified the event to WHO under IHR WHO in its Disease Outbreak News ( 31 May, 2018) not recommended any travel and trade restrictions against India and shared the same with all countries However, there were unwarranted trade restrictions by some middle east countries (EMRO) As per Art 43 of IHR (2005), WHO contacted all the countries requesting rationale and relevant scientific information for the public health measures and requested for its reconsideration. Some countries lifted the ban and the matter is being followed with other countries. WHO has now been informed that both the districts are now free from Human Nipah Virus infection among humans. 23

GAPS/Challenges research priorities Route of infection transmission: route from animals to humans, high risk behaviour ( jungle walk, bat disturbance in well, coconut sap/fruit eating, contact with pigs/contaminated articles (grass/fruits/??), travel??, contact with workers from Siliguri/B.Desh in the area, Travel of infected bats (from affected areas flight range), seasonality of virus shedding etc. Burden of disease in animals population (bats/pigs/others?) How long virus survives in environment? (grass/partially eaten fruits etc., sap)

Long Term Measures Detailed survey among animals/wild life (on the basis of infection detected) for risk mapping Study of High risk behavior: for IEC, PPE use etc. Strengthening hospitals: Resilient health facilities with triage area, isolation and quarantine facilities, ICP, bio-medical waste disposal, stockpile of PPEs, disinfectants, logistics, finances. Private sector surveillance and response: big pvt. Hospitals, IAP/IMA, laboratories, ICP etc. Research: drugs, vaccines etc. Development of a National Framework for prevention, control and management of Zoonotic public health threats

26

27

28

29

30

Thanks 31